Distribution Footprint - Veriton Pharma

As a growing global business, we are constantly looking for new partnerships in distribution and licensing of pharmaceutical products.

We are always interested in talking to potential new country distribution partners to help expand our network across the world.

We can help brand partners to in-license their pharmaceutical products in the countries where we operate.

We are also very happy to talk to organisations who would be interested take our products through the licensing process in their countries to widen the availability of our therapies to people with special medical needs.

Veriton Pharma is constantly working to make its products available more easily to patients and physicians around the world.

We have arrangements with distributors in key countries and are actively seeking to grow our network of distributors.

We are always looking to expand our network of overseas distributors. If you are interested in becoming one of our distributors, please send us a message using the contact us form for further information.

We currently have arrangements in place for Greece and the Nordic Countries (Sweden, Denmark, Norway, Finland & Iceland).

Contact details for these companies are:

Greece

aVI Pharma International SA
43 Mesoghion Street
Marousi
Athens 15126
Greece
T: +30 210 6194170; F: +30 210 6194189
info@avipharma.gr
www.avipharma.gr

The Nordic Countries

Navamedic AB
Krokslätts Parkgata 4
400 22 Göteborg
Sweden
T: +46 (0)31 335 11 90; F: +46 (0)31 335 11 99
Info@navamedic.com
www.navamedic.com

Slovenia

Lenis farmacevtika d.o.o.
Litostrojska cesta 52
1000 Ljubljana
Slovenia

T: +386 (0)1 23 50 700; F: +386 (0)1 23 50 729
info@lenis.si
www.lenis.si

What people say

“Thank you for putting together a superb educational day for myself and the other epilepsy nurses. We all learned so much that will help patients...”- Sarah. Epilepsy Specialist Nurse, NHS Wales

“Veriton Pharma truly went that extra mile to ensure a patients emergency medication was supplied at short notice enabling the patient to travel outside the...”- Epilepsy Nurse Specialist, Glasgow

“I am seriously REALLY delighted that you have the licence granted. Yesterday I had to once again administer Epistatus to my son but had the...”- Patients mother; South London.

“Just to say a big thank you for your support with training materials. It was great to have someone on my side trying to sort...”- Clinical Nurse Specialist/Training Lead

“We have ordered certain medicines from Veriton Pharma for many years and find that you are always there when we need you, a friendly contact...”- Procurement Pharmacist; NHS hospital

More testimonials

News

Young Epilepsy and Veriton Pharma Ltd announce key partnership agreement in support of the charity’s ‘Rules 4 Schools’ campaign

Young Epilepsy and Veriton Pharma Ltd (Veriton) have announced a key agreement, where the organisations will work in partnership to deliver the ‘Rules 4 Schools” element of the charity’s newly… Read More

Epistatus^® 10 Mg (In 1 Ml) Oromucosal Solution Midazolam Available on Nhs Prescription Is Approved For Use By Both the Scottish Medicines Consortium (Smc) and the All Wales Medicines Strategy Group (Awmsg)

Epistatus is licensed for use in the treatment of prolonged, acute convulsive seizures in children and adolescents aged 10 to less than 18 years, who have been diagnosed with epilepsy1. Epistatus… Read More

New company name for Special Products Ltd

2nd October 2017: Weybridge, UK: Today, Veriton Pharma Ltd is announced as the new company name for Special Products Ltd. This name change has occurred both to incorporate the company’s… Read More

Epistatus^® 10 mg oromucosal solution midazolam – now available to prescribe

8th September 2017: Special Products Ltd is pleased to announce that Epistatus® 10 mg Oromucosal Solution, Midazolam, is now available to prescribe. The NHS price for a single 10mg in… Read More